Literature DB >> 33617534

Estimation of the case fatality rate based on stratification for the COVID-19 outbreak.

Byungwon Kim1, Seonghong Kim1, Woncheol Jang1, Sungkyu Jung1, Johan Lim1.   

Abstract

This work is motivated by the recent worldwide pandemic of the novel coronavirus disease (COVID-19). When an epidemiological disease is prevalent, estimating the case fatality rate, the proportion of deaths out of the total cases, accurately and quickly is important as the case fatality rate is one of the crucial indicators of the risk of a disease. In this work, we propose an alternative estimator of the case fatality rate that provides more accurate estimate during an outbreak by reducing the downward bias (underestimation) of the naive CFR, the proportion of deaths out of confirmed cases at each time point, which is the most commonly used estimator due to the simplicity. The proposed estimator is designed to achieve the availability of real-time update by using the commonly reported quantities, the numbers of confirmed, cured, deceased cases, in the computation. To enhance the accuracy, the proposed estimator adapts a stratification, which allows the estimator to use information from heterogeneous strata separately. By the COVID-19 cases of China, South Korea and the United States, we numerically show the proposed stratification-based estimator plays a role of providing an early warning about the severity of a epidemiological disease that estimates the final case fatality rate accurately and shows faster convergence to the final case fatality rate.

Entities:  

Year:  2021        PMID: 33617534     DOI: 10.1371/journal.pone.0246921

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  The association between different predictive biomarkers and mortality of COVID-19.

Authors:  Narges Ansari; Mina Jahangiri; Kimia Shirbandi; Mina Ebrahimi; Fakher Rahim
Journal:  Bull Natl Res Cent       Date:  2022-05-31

2.  Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies.

Authors:  Hongyu Qiu; Xin-Yong Yuan; Teresa Cabral; Kathy Manguiat; Alyssia Robinson; Heidi Wood; Chris Grant; Peter McQueen; Garrett Westmacott; Daniel R Beniac; Lisa Lin; Michael Carpenter; Darwyn Kobasa; Tom Gräfenhan
Journal:  Antiviral Res       Date:  2021-11-08       Impact factor: 5.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.